Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A model assessing potential benefits of isolation and mass testing on COVID-19: the case of Nigeria

View ORCID ProfileFaraimunashe Chirove, Chinwendu E. Madubueze, Zviiteyi Chazuka, Sunday Madubueze
doi: https://doi.org/10.1101/2020.09.01.20186288
Faraimunashe Chirove
1University of Johannesburg, Department of Mathematics and Applied Mathematics, South Africa E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Faraimunashe Chirove
  • For correspondence: fchirove{at}uj.ac.za fchirove{at}uj.ac.za
Chinwendu E. Madubueze
2Federal University of Agriculture, Department of Mathematics, Statistics and Computer Science, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zviiteyi Chazuka
3Chinhoyi University of Technology, School of Natural Sciences and Mathematics, Zimbabwe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunday Madubueze
4Dalhatu Araf Specialist Hospital, Department of Family Medicine, Lafia, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: September 2020 to June 2025

AbstractFullPdf
Sep 2020258047
Oct 202055011
Nov 202053020
Dec 202040015
Jan 202143011
Feb 20215605
Mar 202181111
Apr 20218115
May 20219036
Jun 20216806
Jul 20213564
Aug 202136525
Sep 202127111
Oct 202129027
Nov 202122112
Dec 202128010
Jan 20222642
Feb 20222518
Mar 20222327
Apr 20221803
May 202229212
Jun 20221406
Jul 20221203
Aug 20221323
Sep 202222512
Oct 20222316
Nov 20221706
Dec 20221449
Jan 20231556
Feb 20231248
Mar 20231276
Apr 20232336
May 202312213
Jun 2023758
Jul 2023927
Aug 202317139
Sep 2023945
Oct 20231344
Nov 20231025
Dec 2023915
Jan 2024804
Feb 20241032
Mar 20241965
Apr 20241455
May 20241622
Jun 20247127
Jul 202418311
Aug 20241777
Sep 20241118
Oct 20241377
Nov 202422610
Dec 202471015
Jan 20251057
Feb 20258256
Mar 202532466
Apr 20251575
May 202515129
Jun 2025211
Back to top
PreviousNext
Posted September 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A model assessing potential benefits of isolation and mass testing on COVID-19: the case of Nigeria
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A model assessing potential benefits of isolation and mass testing on COVID-19: the case of Nigeria
Faraimunashe Chirove, Chinwendu E. Madubueze, Zviiteyi Chazuka, Sunday Madubueze
medRxiv 2020.09.01.20186288; doi: https://doi.org/10.1101/2020.09.01.20186288
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A model assessing potential benefits of isolation and mass testing on COVID-19: the case of Nigeria
Faraimunashe Chirove, Chinwendu E. Madubueze, Zviiteyi Chazuka, Sunday Madubueze
medRxiv 2020.09.01.20186288; doi: https://doi.org/10.1101/2020.09.01.20186288

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)